Abstract
Bacteriophage T4 is a virus with well-known genetics, structure, and biology. Such techniques as X-ray crystallography, cryo-EM, and three-dimensional (3D) image reconstruction allowed describing its structure very precisely. The genome of this bacteriophage was completely sequenced, which opens the way for the use of many molecular techniques, such as site-specific mutagenesis, which was widely applied, e.g., in investigating the functions of some essential T4 proteins. The phage-display method, which is commonly applied in bacteriophage modifications, was successfully used to display antigens (PorA protein, VP2 protein of vvIBDV, and antigens of anthrax and HIV) on T4’s capsid platform. As first studies showed, the phage-display system as well as site-specific mutagenesis may also be used to modify interactions between phage particles and mammalian cells or to obtain phages infecting species other than the host bacteria. These may be used, among others, in the constantly developing bacteriophage therapy. All manipulations of this popular bacteriophage may enable the development of vaccine technology, phage therapy, and other branches of biological and medical science.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- Cryo-EM:
-
cryo-electron microscopy
- CSFV:
-
classical swine fever virus
- dsDNA:
-
double stranded DNA
- EF:
-
edema factor
- LF:
-
lethal factor
- LPS:
-
lipopolysaccharide
- LTFs:
-
long tail fibers
- PA:
-
protective antigen
- PDPs:
-
phage-display peptides
- PDPs:
-
phage-display peptides
- vvIBDV:
-
very virulent infectious bursal disease virus
References
Ackermann H.W., Krisch H.: A catalogue of T4-type bacteriophages. Arch.Virol. 142,2329–2345 (1997).
Bateman A., Eddy S.R., Mesyanzhinov V.V.: A member of the immunoglobulin superfamily in bacteriophage T4. Virus Genes 14, 163–165 (1997).
Benhar I.: Biotechnological applications of phage and cell display. Biotechnol.Adv. 19, 1–33 (2001).
Bernstein H., Bernstein C.: Bacteriophage T4 genetic homologies with bacteria and eucaryotes. J.Bacteriol. 171, 2265–2270 (1989).
Birge E.A: T4 bacteriophage as a model genetic system, pp. 89–123 in Bacterial and Bacteriophage Genetics. Springer-Verlag, New York 2006.
Borysowski J., Gorski A.: Phage-display method in experimental therapy of cancer. (In Polish) Postepy Hig.Med.Dośw. 58, 100–107 (2004).
Cao J., Sun Y., Berglindh T., Mellgard B., Li Z., Mardh B., Mardh S.: Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth. Biochim.Biophys.Acta 1474, 107–113 (2000).
Conley M.P., Wood W.B.: Bacteriophage T4 whiskers: a rudimentary environment-sensing device. Proc.Nat.Acad.Sci.USA 72, 3701–3705 (1975).
Dabrowska K., Opolski A., Wietrzyk J., Switała-Jeleń K., Boratynski J., Nasulewicz A., Lipinska L., Chybicka A., Kujawa M., Zabel M., Dolinska-Krajewska B., Piasecki E., Weber-Dabrowska B., Rybka J., Salwa J., Wojdat E., Nowaczyk M., Gorski A.: Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of β3 integrin signaling pathway. Ada Virol. 48, 241–248 (2004a).
Dabrowska K., Opolski A., Wietrzyk J., Switała-Jeleń K., Godlewska J., Boratynski J., Nasulewicz A., Lipinska L.: Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumor models. Anticancer Res. 24, 3991–3995 (2004b).
Dabrowska K., Switała-Jelen K., Weber-Dabrowska B., Gorski A.: Bacteriophage penetration in vertebrates. JAppl.Microbiol. 98,7–13 (2005).
Dabrowska K., Zembala M., Boratynski J., Kujawa M., Switała-Jeleń K, Wietrzyk J., Opolski A., Szczaurska K., Godlewska J., Gorski A.: Hoc protein regulates the biological effects of T4 phage in mammals. Arch.Microbiol. 187,489–498 (2007).
Di Giovine M., Salone B., Martina Y., Amati V., Zambruno G., Cundari E., Failla C.M., Saggio I.: Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage. Virology 282, 102–112 (2001).
Efimov V.P., Nepluev I.V., Mesyanzhinov V.V.: Bacteriophage T4 as a surface display vector. Virus Genes 10, 173–177 (1995).
Fernandez-Gacio A., Uguen M., Fastrez J.: Phage display as a tool for the directed evolution of enzymes. Trends Biotechnol. 21,408–414 (2003).
Fokine A., Chipman P.R., Leiman P.G., Mesyanzhinow V.V., Rao V.B.: Molecular architecture of the prolate head of bacteriophage T4. Proc.Nat.Acad.Sci.USA 101, 6003–6008 (2004).
Gorski A., Borysowski J., Miedzybrodzki R., Weber-Dabrowska B.: Bacteriophages in medicine, pp. 125–157 in S. McGrath, D. van Sinderen (Eds): Bacteriophage Genetics and Molecular Biology. Horizon Scientific Press, Norfolk (UK) 2007.
Hashemolhosseini S., Montag D., Kramer L., Henning U.: Determinants of receptor specificity of coliphages of the T4 family. A chaperone alters the host range. J.Mol.Biol. 241, 524–533 (1994).
Häusler T.: Bug killers. Nature Med. 12, 600–601 (2006).
Jijang J., Abu-Shilbayeh L., Rao V.B.: Display of PorA peptide from Neisseria meningitidis on the bacteriophage T4 capsid surface. Infect.Immun. 65, 4770–4777 (1997).
Karam J.D., Konigsberg W.H.: DNA polymerase of the T4-related bacteriophages. Progr.Nucl.Acid Res.Mol.Biol. 64, 65–96 (2000).
Kniotek M., Ahmed A.M.A., Dabrowska K., Switała-Jelen K., Opolski A., Gorski A.: Bacteriophage interactions with T cells and platelets, pp. 189–192 in Cytokine Network, Regulatory Cells, Signalling, and Apoptosis (Immunology). Monduzzi Editors, Bologna (Italy) 2004.
Konthur Z., Walter G.: Automation of phage display for high-throughput antibody development. Targets 1, 30–36 (2002).
Kricker M.C., Drake J.W.: Heat mutagenesis in bacteriophage T4: another walk down the transversion pathway. J.Bacteriol. 172,3037–3039 (1990).
Kuhn A., Keller B., Meader M., Traub F.: Prohead core of bacteriophage T4 can act as an intermediate in the head assembly pathway. J.Virol. 61, 113–118 (1986).
Kunkel T.A., Loeb L.A., Goodman M.F.: On the fidelity of DNA replication. The accuracy of T4 DNA polymerases in copying φX174 DNA in vitro. J.Biol.Chem. 259, 1539–1545 (1984).
Kutter E.: Phage Therapy: Bacteriophages as Antibiotics. Evergreen State College. Olympia (WA, USA) 1997.
Leiman P.G., Kanamaru S., Mesyanzhinov V.V., Arisaka F., Rossmann M.G.: Structure and morphogenesis of bacteriophage T4. Cel.Mol.Life Sci. 60, 2356–2370 (2003).
Lorch A.: Bacteriophages: an alternative to antibiotics? Biotechnol.Develop.Monitor 39, 14–17 (1999).
Merril C.R., Biswas B., Carlton R., Jensen N.C., Creed G.J., Zullo S., Adhya S.: Long-circulating bacteriophage as antibacterial agents. Proc.Nat.Acad.Sci.USA 93, 3188–3192 (1995).
Merril C.R., Scholl D., Adhya S.L.: The prospect for bacteriophage therapy in western medicine. Nature Rev.Drug Disc. 2, 489–497 (2003).
Mesyanzhinov V.V., Leiman P.G., Kostyuchenko V.A., Kurochkina L.P., Miroshnikov K.A., Sykilinda N.N., Shneider M.M.: Molecular architecture of bacteriophage T4. Biochemistry 69, 1190–1202 (2004).
Mullen L.M., Nair S.P., Ward J.M., Rycroft A.N., Henderson B.: Phage display in the study of infectious diseases. Trends Microbiol. 14, 141–147 (2006).
Nilsson F., Tarli L., Viti F., Neri D.: The use of phage display for the development of tumor targeting agents. Adv.Drug Deliv.Rev. 43, 165–196 (2000).
Olson N.H., Gingery M., Eiserling F.A., Baker T.S.: The structure of isomeric capsids of bacteriophage T4. Virology 279, 385–391 (2001).
O’Malley S.M., Sattar A.K., Williams K.R., Spicer E.K: Mutagenesis of the COOH-terminal region of bacteriophage T4 regA protein. J.Biol.Chem. 270, 5107–5114 (1995).
Paschke M.: Phage display systems and their applications. Appl.Microbiol.Biotechnol. 70, 2–11 (2006).
Pirisi A.: Phage therapy-advantages over antibiotics. Lancet 356, 1418 (2000).
Ren Z.J., Black L.W.: Phage T4 SOC and HOC display of biologically active, full-length proteins on the viral capsid. Gene 215, 439–444 (1998).
Rennell D., Bouvier S.E., Hardy L.W., Poteete A.R.: Systematic mutation of bacteriophage T4 lysozyme. J.Mol.Biol. 222, 67–88 (1991).
Sathaliyawala T., Rao M., MacLean D.M., Birx D.L., Alving C.R., Rao V.B.: Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines. Virol. 80, 7688–7698 (2006).
Schrock R.D. III, LLOYD R.S.: Site-directed mutagenesis of the NH2 terminus of T4 endonuclease V. The position of the α-NH2 moiety affects catalytic activity. J.Biol.Chem. 268, 880–886 (1993).
Selick H.E., Kreuzer K.N., Alberts B.M.: The bacteriophage T4 vector system A method for introducing site-specific mutations into the virus chromosome. J.Biol.Chem. 263, 11336–11347 (1988).
Sergeeva A., Kolonin M.G., Molldrem J.J., Pasqualini R., Arap W.: Display technologies: application for the discovery of drug and gene delivery agents. Adv.Drug Deliv.Rev. 58, 1622–1654 (2006).
Shivachandra S.B., Li Q., Peachman K.K., Matyas G.R., Leppla S.H., Alving C.R., Rao M., Rao V.B.: Multicomponent anthrax toxin display and delivery using bacteriophage T4. Vaccine 25, 1225–1235 (2006).
Smith G.P.: Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315–1316(1985).
Stone R.: Stalin’s forgotten cure. Science 298, 728–731 (2002).
Sulakvelidze A., Alavidze Z., Morris J.G. Jr.: Bacteriophage therapy. Antimicrob.Agents Chemother. 45, 649–659 (2001).
Switala-Jelen K., Dabrowska K., Gorski A., Sliwa L.: Mutations in bacteriophage T4 genome. Ada Virol. 46, 57–62 (2002).
Tðart F., Repoila F., Monod C, Kirsch H.M.: Bacteriophage T4 host range is expanded by duplications of a small domain of the tail fiber adhesion. J.Mol.Biol. 258, 726–731 (1996).
Weber-Dabrowska B., Mulczyk M., Gorski A.: Bacteriophage therapy of bacterial infections: an update of our institute experience. Arch.Immunol.Ther.Exp. 48, 547–551 (2000).
Willats W.G.T.: Phage display: practicalities and prospects. Plant Mol.Biol. 50, 837–854 (2002).
Wu J., Tu C, Yu X., Zhang M., Zhang N., Zhao M., Nie W., Ren Z.: Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: A powerful immunological approach. J.Virol.Meth. 139,50–60 (2006).
Yoichi M., Abe M., Miyanaga K., Unno H., Tanji Y.: Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7. J.Biotechnol. 115,101–107 (2005).
Yong-Chang C, Quan-Cheng S., Jing-Yun M., Quing-Mei X., Ying-Zuo B.: Vaccination against very virulent infectious bursal disease virus using recombinant T4 bacteriophage displaying viral protein VP2. Acta Biochem.Biophys.Sinica 37, 657–664 (2005).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kurzępa, A., Dąbrowska, K., Świtała-Jeleń, K. et al. Molecular modification of T4 bacteriophage proteins and its potential application — Review . Folia Microbiol 54, 5–15 (2009). https://doi.org/10.1007/s12223-009-0002-0
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-009-0002-0